World’s First Malaria Drug for Infants and Babies Approved by Swiss Authorities:

Swiss regulators have granted approval to Coartem, a breakthrough malaria medication by Novartis designed for infants and young children — a demographic most vulnerable to malaria deaths, particularly in Africa. This landmark development addresses a critical global health gap, especially since over half a million lives were lost to malaria in 2023, mostly among children under five.